Clara Biotech
Indianapolis, IN
Platform Provider
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
56.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Clara Biotech
- Signal Score
- 56.5/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Indianapolis, IN
- Modalities
- Exosome
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Clara Biotech
CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesExosome
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Indianapolis, IN
Modalities: Exosome
Capacity assessment: 53.0/100
Sites: Indianapolis, IN
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Indianapolis, IN
Modalities: Exosome
Capacity assessment: 53.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About Clara Biotech
What is Clara Biotech's CDMO Signal Score?
Clara Biotech has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Clara Biotech for a manufacturing program?
Use the free AI matchmaker to compare Clara Biotech against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Esco Aster
Singapore, Singapore
Signal Score: 63.0
Cell Therapy, Exosome
Codiak BioSciences (Sarepta)
Cambridge, MA
Signal Score: 60.3
Exosome
ExoXpert (EXO Biologics)
Liège, Belgium
Signal Score: 56.5
Exosome
Evox Therapeutics
Oxford, United Kingdom
Signal Score: 56.5
Exosome
Exopharm
Melbourne, Australia
Signal Score: 56.5
Exosome
Compare Clara Biotech with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.